Local Control After Robot-assisted Supraglottic Laryngectomy

Hospices Civils de Lyon122 enrolled

Overview

Transoral robotic surgery is an option to treat supraglottic squamous cell carcinomas. Oncological outcomes 2 years after transoral robotic surgery for supraglottic laryngectomy were studied.

Study Type

OBSERVATIONAL

Enrollment

122

Conditions

Supraglottic Squamous Cell Carcinoma

Interventions

Transoral robotic surgery (TORS)PROCEDURE

All patients underwent primary tumour resection with transoral robotic surgery (TORS) using the daVinci robot (Intuitive Surgical, Sunnyvale CA)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Men or women over 18 years of age * Patients with supra-glottic squamous cell carcinoma from T1 to T3, all stages N * Patients with a robot assisted supra-glottic laryngectomy with at least 2 years follow-up Exclusion Criteria: * Patients for whom follow-up of at least 2 years has not been achieved; * Major patients protected by the law (under guardianship or guardianship); * Patients who expressed opposition to their participation in the study.

Locations (1)

Croix-Rousse Hospital, Hospices Civils de Lyon

Lyon, France

Outcomes

Primary Outcomes

Local control

Proportion of patients without cancer recurrence 2 years after surgery

Time frame: 2 years after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.